Smart Needle
Syringes and hollow needles—among the most feared and most commonly used tools in medical practice—have been around for more than a century.
However, the precise insertion of these devices depends largely on the technique and skill of the person delivering the injection. And some anatomical regions, such as the space in the back of the eye, can be particularly tricky, and indeed risky, to inject.
Now research led by Harvard Medical School scientists at Brigham and Women’s Hospital have developed a highly sensitive intelligent injector for tissue targeting (i2T2) that detects changes in resistance in order to properly and safely deliver medication.
Their results, based on work done in preclinical models, are published Feb. 25, in Nature Biomedical Engineering.
“Targeting specific tissues using a conventional needle can be difficult and often requires a highly trained individual,” said senior corresponding author Jeffrey Karp, HMS professor of medicine at Brigham and Women’s. “In the past century there has been minimal innovation to the needle itself, and we saw this as an opportunity to develop better, more accurate devices. We sought to achieve improved tissue targeting while keeping the design as simple as possible for ease of use.”
One area that is difficult to target with a standard needle is the suprachoroidal space (SCS), located between the sclera and choroid in the back of the eye. The SCS has emerged as an important location for medication delivery but is challenging to inject precisely and safely because the needle must stop after transitioning through the sclera, which is less than 1 millimeter thick—about half as thick as a U.S. quarter. Injecting this region carries a risk for retinal damage. Other common tissue targets include the epidural space around the spinal cord, used for epidural anesthesia to ease pain during labor, the peritoneal space in the abdomen, and subcutaneous tissue between the skin and muscles, one of the most common sites of injection.
The i2T2 device was fabricated using a standard hypodermic needle and parts from commercially available syringes. Different types of tissues have different densities and as a result exert different pressure and different resistance to penetrating objects. The intelligent injector harnesses these differences to enable needle movement in a tissue-specific manner.
The driving force, maximal forces and frictional force of the injector were tested using a universal testing machine. The feedback to the injector is instantaneous, which allows for better tissue targeting and minimal needle overshoot past the desired location.
The i2T2 was tested on tissue from three animal models to examine delivery accuracy in the suprachoroidal, epidural and peritoneal spaces, as well as subcutaneously. Using both extracted tissue and an animal model, the researchers found that the i2T2 prevented overshoot injuries and precisely delivered medication to the desired location without any additional training or specialized technique.
In preclinical models, the researchers reported high coverage of contrast agent in the posterior section of the eye, indicating that the payload had been injected into the correct location. The experiments also showed the injector could be used to safely deliver stem cells to the back of the eye, which can be useful for regenerative therapies.
“The stem cells injected into the SCS survived, indicating that the force of injection and the transit through the SCS were gentle on the cells,” said Kisuk Yang, a co-author and HMS research fellow in medicine at Brigham and Women’s. “This should open the door to regenerative therapies for patients suffering from conditions of the eye and beyond.”
“We have optimized a staple of modern medicine into a more intelligent device capable of more precise tissue targeting and with a better safety profile,” said first author Girish Chitnis, a former postdoctoral fellow in Karp’s laboratory. “We hope that we will be able to adapt this technology for human use in the very near future.”
“The i2T2 will help facilitate injections in difficult-to-target locations in the body,” said co-author Miguel González-Andrades, HMS research fellow in ophthalmology at Massachusetts Eye and Ear and collaborator with Karp’s lab. “The next step toward human use is to demonstrate the utility and safety of the technology in relevant preclinical disease models.”
Learn more: Smart Needle
The Latest on: Smart Needle
[google_news title=”” keyword=”Smart Needle” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Smart Needle
- AI-powered smart contracts could be ‘transformative’ — Ava Labs founderon May 8, 2024 at 6:15 am
Avalanche has begun building a new virtual machine programmed in natural language, which is at the intersection of AI and blockchains.
- Shameless Judge Cannon May Have Killed Trump’s Classified Docs Caseon May 7, 2024 at 7:47 am
Trump is facing 34 felony charges for allegedly falsifying business records with the intent to further an underlying crime, and has pleaded not guilty. Daniels and Cohen have yet to testify, and when ...
- How Do Credit Cards Impact Your Mortgage Application?on May 6, 2024 at 9:00 am
Qualifying for a mortgage is hard enough amongst high home prices and interest rates. But these high costs mean that qualifying for the best possible rate is more important than ever. While many ...
- Smart Syringe Market Future of Market Size A Catalyst for Business Transformationon May 5, 2024 at 3:55 pm
Smart Syringe Market is valued approximately at USD 6.8 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 8.7% over the forecast period 2020-2027. Smart syringes are ...
- Stellar Smart Contracts Bring DeFi to the “Real World”on April 29, 2024 at 5:00 pm
Focusing on accessibility and the specific needs of the many is how Stellar and Soroban Smart Contracts have truly moved the needle on democratizing finance. In recognizing that there is a world of ...
- Smart Biopsy Devices Market Sizing Up Success Unlocking New Avenues in the Market of Tomorrowon April 25, 2024 at 9:46 pm
Smart Biopsy Devices Market is valued at approximately USD 2.5 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 5.7% over the forecast period 2020-2027. Biopsy is a ...
- Top 8 Best Embroidery Machines in 2024on April 19, 2024 at 4:59 pm
The 3.7″ Sew Smart color LCD touch screen display allows you to view your designs in full color before stitching, ensuring that you get the perfect result every time. The automatic needle ...
- Here's Why This Smart Water Meter Company's Stock Surged 23% This Weekon April 19, 2024 at 3:45 am
Smart internet-enabled technology adds value to their solutions ... Based on that, investors shouldn't expect federal spending to move the needle much for this company in the future. Moreover, ...
- Conference Newson April 2, 2024 at 4:59 pm
News, September 09, 2020 MOA 2020 Novel Smart Needle System Reduces Risk of Filler Complications Currently, in order to determine if the needle is in a blood vessel, physicians pull back on the ...
- Smart home hubs: what they are and why you need oneon March 7, 2024 at 6:04 am
Yes, it’s 2024, and you still need a hub The new smart home standard Matter is moving the needle on interoperability in the smart home, but it still has a long way to go. Today, you need a hub to ...
via Bing News